GlassScriptPhysician profile
Sarah C Barr
NPI 1588853238
$2,476.83
in general payments reported to CMS, 2019-2025
17 companies · $1,114 in 2025
The $1,114 reported for 2025 was more than what 82% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $560 · 2022: $334 · 2023: $293 · 2024: $176 · 2025: $1,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,583.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $568.40 | 2021-2025 | General - Therapies, General - Brady, General - Tachy |
| Abbott Laboratories | $442.23 | 2021-2025 | Triclip |
| Medtronic, INC. | $406.27 | 2021-2025 | Linq II, Micra, Venaseal |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $311.12 | 2021-2025 | Lifevest |
| Edwards Lifesciences Corporation | $175.59 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Impulse Dynamics (USA) INC. | $175.15 | 2021-2022 | |
| Biosense Webster, INC. | $128.06 | 2025 | Carto 3 |
| Pfizer INC. | $51.54 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $39.62 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $36.53 | 2023 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $28.73 | 2025 | Amvuttra |
| Atricure, INC. | $24.93 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $20.47 | 2023 | Opsumit, Uptravi |
| Bayer Healthcare Pharmaceuticals INC. | $19.54 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.10 | 2023 | Jardiance |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $15.27 | 2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $14.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Barr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.